| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |